Narum, Marte
Christensen, Jacob Juel
Holven, Kirsten B.
Berg, Tore Julsrud
Sveen, Kari Anne
Funding for this research was provided by:
University of Oslo
Article History
Received: 15 May 2025
Accepted: 27 June 2025
First Online: 23 July 2025
Declarations
:
: The study was approved by the regional ethics committee (project no. 2014/851). The study conformed to the Declaration of Helsinki.
: Not applicable.
: Dr. Christensen has received personal fees from Novo Nordisk and Falck Helse, not related to the content of this manuscript. Dr. Holven has received personal fees from Sanofi and Ultragenyx, none of which are related to the content of this manuscript. The other authors have nothing to disclose.